why choose us

First received: October 07, 2023

Clinical Trial: A Study to Evaluate XTR006 in Chinese Volunteers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Alzheimer Disease

Study Type: INTERVENTIONAL


Official Title: A Phase I Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of XTR006 in Healthy Chinese Volunteers

Brief Summary: XTR006 is a 18F-labeled positron emission tomography ?PET?tracer for imaging tau protein in the brain.This phase I study investigated the safety, biodistribution, radiation dosimetry and Pharmacokinetics of XTR006 in 10 healthy elderly Chinese volunteers.

Read more